Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alon Marmor

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Israel Medical Association Journal : IMAJ|May 12, 2007
Assessment of a new non-invasive index of cardiac performance for detection of dobutamine-induced myocardial ischemiaMiguel Gorenberg, Alon Marmor
Cardiovascular Engineering (Dordrecht, Netherlands)|March 5, 2009
A new noninvasive device for measuring central ejection dP/dt mathematical foundation of cardiac dP/dt measurement using a model for a collapsible arteryMiguel Gorenberg, Hector Rotztein, Alon Marmor
The Journal of Invasive Cardiology|January 9, 2008
Buddy wire, buddy balloon or better together!Alexander Goldberg, Roberto Klein, Alon Marmor
Indian Pacing and Electrophysiology Journal|February 14, 2008
Hemoptysis--a rare complication of pacemaker implantationAlexander Goldberg, Inna Rosenfeld, Alon Marmor
BMJ Case Reports|July 18, 2012
Unilateral presentation of postpartum cardiomyopathy misdiagnosed as pneumoniaBen Hayman Amit, Alon Marmor, Amer Hussein
Radiology|January 23, 2010
Presence of coronary plaques in patients with nonalcoholic fatty liver diseaseNimer Assy, Agness Djibre, Raymond Farah, et al.
Journal of the American College of Cardiology|January 22, 2003
RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled studyEdo Kaluski, Isaac Kobrin, Reuven Zimlichman, et al.
Lancet (London, England)|March 31, 2009
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb studyJohn R Teerlink, Marco Metra, G Michael Felker, et al.
American Heart Journal|April 8, 2003
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 studyGad Cotter, Christopher P Cannon, Carolyn H McCabe, et al.
Lancet (London, England)|November 13, 2012
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialJohn R Teerlink, Gad Cotter, Beth A Davison, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Israel Medical Association Journal : IMAJ|May 12, 2007
Assessment of a new non-invasive index of cardiac performance for detection of dobutamine-induced myocardial ischemiaMiguel Gorenberg, Alon Marmor
Cardiovascular Engineering (Dordrecht, Netherlands)|March 5, 2009
A new noninvasive device for measuring central ejection dP/dt mathematical foundation of cardiac dP/dt measurement using a model for a collapsible arteryMiguel Gorenberg, Hector Rotztein, Alon Marmor
The Journal of Invasive Cardiology|January 9, 2008
Buddy wire, buddy balloon or better together!Alexander Goldberg, Roberto Klein, Alon Marmor
Indian Pacing and Electrophysiology Journal|February 14, 2008
Hemoptysis--a rare complication of pacemaker implantationAlexander Goldberg, Inna Rosenfeld, Alon Marmor
BMJ Case Reports|July 18, 2012
Unilateral presentation of postpartum cardiomyopathy misdiagnosed as pneumoniaBen Hayman Amit, Alon Marmor, Amer Hussein
Radiology|January 23, 2010
Presence of coronary plaques in patients with nonalcoholic fatty liver diseaseNimer Assy, Agness Djibre, Raymond Farah, et al.
Journal of the American College of Cardiology|January 22, 2003
RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled studyEdo Kaluski, Isaac Kobrin, Reuven Zimlichman, et al.
Lancet (London, England)|March 31, 2009
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb studyJohn R Teerlink, Marco Metra, G Michael Felker, et al.
American Heart Journal|April 8, 2003
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 studyGad Cotter, Christopher P Cannon, Carolyn H McCabe, et al.
Lancet (London, England)|November 13, 2012
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialJohn R Teerlink, Gad Cotter, Beth A Davison, et al.
Pageof 2